$1.69 Billion is the total value of PARTNERS CAPITAL INVESTMENT GROUP, LLP's 132 reported holdings in Q3 2022. The portfolio turnover from Q2 2022 to Q3 2022 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| USHY | New | iShares Broad USD High Yield Corporate Bond ETFbroad usd high | $27,086,000 | – | 805,639 | +100.0% | 1.60% | – |
| XOM | New | Exxon Mobil Corp | $8,926,000 | – | 102,230 | +100.0% | 0.53% | – |
| BMY | New | Bristol-Myers Squibb Co | $7,944,000 | – | 111,751 | +100.0% | 0.47% | – |
| ORCL | New | Oracle Corp | $6,377,000 | – | 104,423 | +100.0% | 0.38% | – |
| UTHR | New | United Therapeutics Corp | $3,377,000 | – | 16,129 | +100.0% | 0.20% | – |
| CRWD | New | Crowdstrike Holdings Inccl a | $3,348,000 | – | 20,317 | +100.0% | 0.20% | – |
| ZS | New | Zscaler Inc | $3,352,000 | – | 20,392 | +100.0% | 0.20% | – |
| ARGX | New | Argenx SEsponsored adr | $3,299,000 | – | 9,345 | +100.0% | 0.20% | – |
| CPNG | New | Coupang Inccl a | $3,195,000 | – | 191,636 | +100.0% | 0.19% | – |
| PDD | New | Pinduoduo Incsponsored ads | $1,909,000 | – | 30,500 | +100.0% | 0.11% | – |
| EMXC | New | iShares MSCI Emerging Markets ex China ETFmsci emrg chn | $1,728,000 | – | 39,028 | +100.0% | 0.10% | – |
| HLT | New | Hilton Worldwide Holdings Inc | $1,320,000 | – | 10,947 | +100.0% | 0.08% | – |
| ANTM | New | Elevance Health Inc | $1,316,000 | – | 2,898 | +100.0% | 0.08% | – |
| EA | New | Electronic Arts Inc | $1,303,000 | – | 11,261 | +100.0% | 0.08% | – |
| CRM | New | salesforce.com Inc | $1,290,000 | – | 8,969 | +100.0% | 0.08% | – |
| IWM | New | iShares Russell 2000 ETFrussell 2000 etf | $1,208,000 | – | 7,326 | +100.0% | 0.07% | – |
| REZ | New | iShares Residential and Multisector Real Estate ETFresidential mult | $1,035,000 | – | 14,417 | +100.0% | 0.06% | – |
| VTEB | New | Vanguard Tax-Exempt Bond Index ETFtax exempt bd | $1,001,000 | – | 20,798 | +100.0% | 0.06% | – |
| BIL | New | SPDR Bloomberg 1-3 Month T-Bill ETFbloomberg 1-3 mo | $751,000 | – | 8,197 | +100.0% | 0.04% | – |
| HZNP | New | Horizon Therapeutics Plc | $654,000 | – | 10,574 | +100.0% | 0.04% | – |
| XBI | New | SPDR S&P Biotech ETFs&p biotech | $266,000 | – | 3,353 | +100.0% | 0.02% | – |
| IBBQ | New | Invesco Nasdaq Biotechnology ETFnasdaq biotech | $242,000 | – | 12,806 | +100.0% | 0.01% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| iShares Core S&P 500 ETF | 24 | Q3 2023 | 12.6% |
| Vanguard Value ETF | 24 | Q3 2023 | 16.6% |
| iShares Core MSCI Emerging Markets ETF | 24 | Q3 2023 | 10.8% |
| iShares Currency Hedged MSCI EAFE ETF | 24 | Q3 2023 | 6.3% |
| Microsoft Corp | 24 | Q3 2023 | 5.4% |
| TransDigm Group Inc | 24 | Q3 2023 | 4.7% |
| iShares Global REIT ETF | 24 | Q3 2023 | 2.7% |
| Vanguard Total World Stock ETF | 24 | Q3 2023 | 3.8% |
| iShares TIPS Bond ETF | 24 | Q3 2023 | 3.1% |
| Yum! Brands Inc | 24 | Q3 2023 | 2.5% |
View PARTNERS CAPITAL INVESTMENT GROUP, LLP's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| SC 13G | 2024-02-06 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR/A | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR | 2022-05-16 |
View PARTNERS CAPITAL INVESTMENT GROUP, LLP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.